Publications by authors named "David Shoultz"

Claim this Profile
V
Vital lessons from struggling partnerships and potential partnerships: an international study with leaders across the health sector.
Greg Zwisler, Christopher Martin Sauer, David Shoultz

BMC Health Serv Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Maria Rebelo, Cong Tang, Ana R Coelho, Carlos Labão-Almeida, Matthias M Schneider, David Shoultz

J Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.
Ibrahim A Khalil, Christopher Troeger, Brigette F Blacker, Puja C Rao, Alexandria Brown, David A Shoultz

Lancet Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study.
Ibrahim A Khalil, Christopher Troeger, Puja C Rao, Brigette F Blacker, Alexandria Brown, David A Shoultz

Lancet Glob Health· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric cryptosporidiosis: An evaluation of health care and societal costs in Peru, Bangladesh and Kenya.
Ellen R Rafferty, Janna M Schurer, Michael B Arndt, Robert K M Choy, Eugenio L de Hostos, David Shoultz

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality.
David A Shoultz, Eugenio L de Hostos, Robert K M Choy

PLoS Negl Trop Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
Alan D Tice, Pamela A Hoaglund, David A Shoultz

Am J Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and treatment outcomes in osteomyelitis.
Alan D Tice, Pamela A Hoaglund, David A Shoultz

J Antimicrob Chemother· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors.
Ron Palmon, Bon Chang A Koo, David A Shoultz, Douglas T Dieterich

J Acquir Immune Defic Syndr· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis